New hope for patients with Life-Threatening seizures that Won't stop
NCT ID NCT02433314
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 30 times
Summary
This study provides access to an experimental drug, SAGE-547, for people aged 6 months and older with super-refractory status epilepticus—a dangerous condition where seizures continue despite standard treatments. The drug is given as a continuous IV infusion to try to stop the seizures. The goal is to control the condition, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUPER-REFRACTORY STATUS EPILEPTICUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.